America Great Health
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its nam… Read more
America Great Health (AAGH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 0.009x
Based on the latest financial reports, America Great Health (AAGH) has a cash flow conversion efficiency ratio of 0.009x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-53.50K) by net assets ($-5.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
America Great Health - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how America Great Health's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
America Great Health Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of America Great Health ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HBM Healthcare Investments
SW:HBMN
|
0.000x |
|
Viji Finance Limited
NSE:VIJIFIN
|
0.017x |
|
MAS Gold Corp
PINK:MSGCF
|
-0.024x |
|
Orgabio Holdings Bhd
KLSE:0252
|
0.122x |
|
Albion Resources Ltd
AU:ALB
|
-0.283x |
|
Exent Corp
PINK:EXNN
|
2.093x |
|
Indo Pureco Pratama Tbk PT
JK:IPPE
|
0.000x |
|
Norse Gold Corp
V:VKG-H
|
-0.025x |
Annual Cash Flow Conversion Efficiency for America Great Health (2011–2025)
The table below shows the annual cash flow conversion efficiency of America Great Health from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-5.31 Million | $-615.63K | 0.116x | -30.33% |
| 2024-06-30 | $-4.53 Million | $-752.90K | 0.166x | 0.00% |
| 2023-06-30 | $-4.53 Million | $-752.90K | 0.166x | -56.60% |
| 2022-06-30 | $-3.86 Million | $-1.48 Million | 0.383x | +108.35% |
| 2021-06-30 | $-215.01K | $-39.56K | 0.184x | 0.00% |
| 2020-06-30 | $-215.01K | $-39.56K | 0.184x | +11.22% |
| 2019-06-30 | $-168.00K | $-27.79K | 0.165x | -62.04% |
| 2018-06-30 | $-107.45K | $-46.83K | 0.436x | -59.07% |
| 2017-06-30 | $-48.07K | $-51.17K | 1.065x | +139.83% |
| 2016-06-30 | $-1.09 Million | $-485.32K | 0.444x | +6451.65% |
| 2015-06-30 | $-992.37K | $-6.72K | 0.007x | -98.29% |
| 2013-06-30 | $-227.27K | $-90.23K | 0.397x | +48.32% |
| 2012-06-30 | $-59.10K | $-15.82K | 0.268x | -94.45% |
| 2011-06-30 | $-2.90K | $-13.97K | 4.821x | -- |